Literature DB >> 32730636

Omalizumab for the treatment of chronic inducible urticaria in 80 patients.

V Exposito-Serrano1, L Curto-Barredo2, P Aguilera Peiro3, S Gómez Armayones3, E Serra-Baldrich4, J Spertino4, M Bonfill Ortí5, I Figueras Nart5, G Melé-Ninot6, C Baliu-Piqué7, A Sala Cunill8, M Labrador-Horrillo8, A Guilabert Vidal9, N Fernández Chico1, A M Giménez-Arnau2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32730636     DOI： 10.1111/bjd.19425

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

Review 2.  Expert consensus on the use of omalizumab in chronic urticaria in China.

Authors:  Zuotao Zhao; Tao Cai; Hong Chen; Liuqing Chen; Yudi Chen; Xiang Gao; Xinghua Gao; Songmei Geng; Yinshi Guo; Fei Hao; Guodong Hao; Yan Hu; Hongzhong Jin; Zhehu Jin; Chengxin Li; Haili Li; Jie Li; Yanming Li; Yunsheng Liang; Guanghui Liu; Qiang Liu; Hai Long; Lin Ma; Yuanyuan Shang; Yuxin Song; Zhiqiang Song; Xiangyang Su; Haijing Sui; Qing Sun; Yuemei Sun; Jianping Tang; Xunliang Tong; Huiying Wang; Gang Wang; Lianglu Wang; Siqin Wang; Li Xiang; Ting Xiao; Zhiqiang Xie; Leping Ye; Yongmei Yu; Chunlei Zhang; Litao Zhang; Shuchen Zhang; Rui Zheng; Lili Zhi; Wei Zhou; Ying Zou; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2021-12-05       Impact factor: 4.084

3.  IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.

Authors:  Ana M Giménez-Arnau; Clara Ribas-Llauradó; Nasser Mohammad-Porras; Gustavo Deza; Ramón M Pujol; Ramón Gimeno
Journal:  Clin Transl Allergy       Date:  2022-02-01       Impact factor: 5.871

4.  Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.

Authors:  Soo Hyun Jeong; Dong Jun Lim; Sung Eun Chang; Kwang Ho Kim; Kwang Joong Kim; Eun Joo Park
Journal:  J Korean Med Sci       Date:  2022-07-11       Impact factor: 5.354
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.